Palomino Laboratories (PALX) Operating Expenses (2023 - 2025)
Palomino Laboratories (PALX) posted Operating Expenses of -$1.9 million for Q4 2025, down 220.27% sequentially from $1.6 million in Q3 2025, and down 1499.08% YoY from $137962.0 in Q4 2024.
Palomino Laboratories (PALX) Operating Expenses (2023 - 2025) Analysis & Trends
Palomino Laboratories has reported Operating Expenses for 3 years, with the latest figure at -$1.9 million in Q4 2025.
- Quarterly Operating Expenses fell 1499.08% year-over-year to -$1.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$271897.0 (down 222.32% YoY) and the FY2025 annual result came in at $30000.0, down 78.58% from the prior year.
- Operating Expenses retreated to -$1.9 million in Q4 2025 per PALX's latest filing, from $1.6 million in the prior quarter.
- Over five years, Operating Expenses peaked at $1.6 million in Q3 2025 and troughed at -$1.9 million in Q4 2025.
- A 3-year average of $2583.1 and a median of $34061.0 in 2023 frame the typical range for Operating Expenses.
- The widest YoY moves for Operating Expenses: up 129958.51% in 2025, down 1499.08% in 2025.
- Over 3 years, Operating Expenses stood at $32574.0 in 2023, then soared by 323.53% to $137962.0 in 2024, then slumped by 1499.08% to -$1.9 million in 2025.
- According to Business Quant data, Operating Expenses over the past three periods registered -$1.9 million, $1.6 million, and $35548.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.93 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 35,548.00 |
| Mar 31, 2025 | 17,828.00 |
| Dec 31, 2024 | 137,962.00 |
| Sep 30, 2024 | 1,234.00 |
| Jun 30, 2024 | 31,791.00 |
| Mar 31, 2024 | 51,304.00 |
| Dec 31, 2023 | 32,574.00 |
| Sep 30, 2023 | 42,863.00 |